Adverse Event Intake and Follow-up Services

Row of customer service professionals wearing headset one person smiling at camera

ProPharma's contact center is trained on Adverse Event (AE) detection and intake since onboarding as part of Medical Information (MI) processing. We ensure that every AE is collected for patients' safety, customer journey, and compliance at every customer interaction. For a seamless experience, ProPharma offers comprehensive AE processing and reporting through our dedicated Pharmacovigilance (PV) team to supplement or fully outsource your existing PV function.

Collaborative, connected, and global

Central Point of Contact

Central Point of Contact

Decentralized Clinical Trials icon

Empathy-Driven Approach

Empathy-Driven Approach

Product compliant intake icon

Identification and Accurate Reporting of Adverse Event

Identification and Accurate Reporting of Adverse Event

Medical writing icon

Documentation and Reporting

Documentation and Reporting

Message received icon

Follow-up Processing

Follow-up Processing

Global contact center support icon

Enhanced Reconciliation and Safety Monitoring

Enhanced Reconciliation and Safety Monitoring

Central Point of Contact

As a trusted partner, ProPharma serves as an extension of your company, acting as a central hub for both your internal staff and external customers in the pre-marketing and post-marketing space. We speak the local language, and able to collect Adverse Events (AEs) and Special Safety Events (SSE) through various reporting channels, including traditional methods like phone and email, as well as newer platforms such as social media and live chat. The ProPharma Medical Information Contact Center (MICC) provides a centralized and streamlined AE reporting process, eliminating duplicate information from different programs and significantly reducing administrative complexity and time in AE processing.

Our global presence ensures easy approach to our contact center, even in crisis situations. Our scalable and adaptable strategies provide continuous business support during spikes in call volume, regulatory changes, or product market withdrawals, offering consistent medical information and safety assistance.

Woman watching a health professional presenting on a laptop

Empathy-Driven Approach

ProPharma's customer engagement strategy emphasizes empathy, transforming the treatment-emergent adverse events (TEAE) to a patient-centric intake experience. Our Medical Information (MI) specialists are trained to address unique patient concerns with compassion, fostering trust and enhancing satisfaction. By prioritizing open communication, we create a holistic support environment that leads to better patient outcomes and promotes a healthy relationship between our client and its stakeholders.

Healthcare provider writing on clipboard while attending to a patient

Identification and Accurate Reporting of Adverse Event

Our customizable AE intake process enhances quality with precision tailored to our client's specific needs. Our accredited MI Team not only experienced in identifying AEs but also in delivering comprehensive and accurate reporting. To ensure they remain at the forefront of a constantly evolving market, our specialists receive continuous training on the latest product knowledge and regulatory requirements. ProPharma's commitment to ongoing education promotes consistency and simplifies quality monitoring, resulting in a seamless and efficient process.

Customer service professional in a contact center wearing headset asking a coworker-a-question

Documentation and Reporting

ProPharma provides an in-house validated database that integrates with Pharmacovigilance (PV) systems, such as Oracle Argus or Veeva Vault Safety, it is designed to simplify workflows, facilitating direct transfers of AE cases for immediate triage and review. With our advanced system, AE cases are delivered quickly to our clients or the ProPharma's dedicated PV teams, allowing for prompt assessment and action. Additionally, it triggers timely report to the regulatory system (i.e., FDA Adverse Event Reporting System (FAERS)), ensures that regulatory requirements are met. ProPharma empowers organizations to maintain high standards of compliance and safety while optimizing operational efficiency.

Hand writing on clipboard with a pen

Follow-up Processing

Utilizing a contact center for Adverse Event Follow-Up (AEFU) provides several significant advantages. Our representatives are trained in pharmacovigilance protocols, ensuring accurate and relevant information is gathered during follow-up calls or communications. ProPharma offers proactive outreach service to patients and healthcare providers to obtain additional details that may not have been captured in the initial report, resulting in a more comprehensive understanding of adverse events. This approach improves operational efficiency, allowing your pharmacovigilance team to concentrate on critical tasks such as data analysis and regulatory compliance. Furthermore, standardized follow-up processes enhance consistency in data collection, which boosts the reliability of reports and aids in safety evaluations. Regular follow-ups also help build trust and engagement with patients and providers, reinforcing a commitment to safety and care.

Row of customer service professionals wearing headsets

Enhanced Reconciliation and Safety Monitoring

ProPharma's activity reporting process provide complete traceability of each AE case and delivers detailed insights into all AE activities. We promote transparency and accountability using systematic documentation. Our automated reconciliation process aligns AE cases between the MI and PV systems, cross-referencing AE case numbers in both databases. With access to our proprietary Business Insights & Analytics (BIA) reporting platform, you'll find comprehensive AE case data and program metrics available 24/7/365. This robust system enhances decision-making and reinforces our commitment to maintaining the highest standards of patient safety and operational efficiency.

Person working on desktop and laptop devices
Person holding pen pointing to tablet device on a table

ProPharma’s Advanced Contact Center Technology in Pharmacovigilance

Efficient Triage with IVR and Call Redirection

Our Interactive Voice Response (IVR) system and call redirection capabilities significantly enhance our triage processes. By efficiently routing calls to the appropriate representatives, we ensure that inquiries related to Adverse Events (AEs) are addressed promptly and accurately. This technology minimizes wait times and improves the overall experience for both patients and healthcare providers.

Smart Report Generation

Our smart report generation tool automates the merging of content directly from the intake process, greatly reducing the potential for errors associated with manual reporting. This streamlined case processing workflow not only improves accuracy but also expedites the generation of essential reports. As a result, our teams can dedicate more time to critical safety assessments and less to administrative tasks.

Automated Follow-Up

Our follow-up automation system streamlines the process of sending forms and collecting additional information through written communication, significantly reducing administrative workloads. By automating these follow-up tasks, we ensure timely communication with stakeholders while freeing up valuable resources within your team. This efficiency enhances our ability to maintain thorough and accurate records of all interactions related to AEs.

Two data professionals reviewing data on computer monitor
Hands typing on tablet device

Advanced Analytics for Duplicated Reports

With advanced analytical tools, we can effectively reconcile the duplicated reports and information. This capability helps identify discrepancies and confirms that all data is accurately reflected in the systems. We help enhancing the integrity of data, which is crucial for making informed safety decisions and maintaining compliance with regulatory standards.

Our Adverse Event Intake Experts

  • Dave Bezick Bio Photo

    Dave Bezick

    Senior Director, Medical Information Service Delivery

    View Bio

  • Hannah Hunter Bio Photo

    Hannah Hunter

    Senior Director, Medical Information

    View Bio

  • Katie Tonge Bio Photo

    Katie Tonge

    Senior Director, Medical Information

    View Bio

  • Leanne Shaw Bio Photo

    Leanne Shaw

    Senior Director, Medical Information

    View Bio

Dave brings over 14 years of Medical Information Contact Center Management and Operations experience. A licensed Registered Nurse, he began his career as a front-line Medical Information Specialist and has continually advanced into roles of increasing responsibility within the Medical Affairs industry. He is currently the Senior Director, Medical Information Service Delivery (Operations and Account Management) at ProPharma. Dave's passion for the patient and HCP experience is evident in his approach to staff selection, employee development and operational excellence of his teams.

Hannah is the Senior Director of Medical Information (MI), Europe at ProPharma, where she leads dedicated client services across the continent. With 17 years of experience in Medical Information, Hannah has supported pharmaceutical companies globally. She is passionate about the evolution of MI to better meet the needs of customers and clients. As a proven leader, Hannah excels in guiding and inspiring her team to achieve excellence. She places a strong emphasis on the provision of telephone-based MI, recognizing its importance as the primary channel for MI inquiries and its potential for excellent service delivery. Additionally, she is focused on leveraging technology to enhance the efficiency and effectiveness of medical information teams.

Katie has over 15 years of Medical Information outsourcing experience, as well as contact centre management, and is passionate about using Medical Information to improve the health and safety of patients. She enjoys working with clients to suggest innovative and commercially sustainable options for their Medical Information needs. She has a track record of establishing service levels and KPIs with clients to ensure the highest standards for customers.  She also has Project Management experience in helping clients transition from in-sourced services to an outsourced Medical information solution.

Leanne brings 14 years of Medical Information Contact Center Management and Operations experience across Europe and Asia Pacific. Leanne begun her career in this space as a UK Medical Information Specialist and has continually advanced into roles of increasing responsibility including client management, operations management, and project leadership. Leanne is currently the Senior Director of Medical Information Services for JAPAC at ProPharma. Leanne’s key focus on service evolution and customer excellence helps deliver JAPAC services to the highest standard of success.

News & Insights

Orchestrating Excellence: How ProPharma Bridges Vendors to Deliver Unified, High-Quality Outcomes

August 7, 2025

Orchestrating Excellence: How ProPharma Bridges Vendors to Deliver Unified, High...

Discover how ProPharma enhances collaboration and quality in drug development by expertly coordinating and communicating with multiple vendors for unified, high-quality outcomes.

European Marketing Authorization Success: The Critical Role of Quality and Compliance

August 4, 2025

European Marketing Authorization Success: The Critical Role of Quality and Compl...

Achieve European market success with robust quality and compliance solutions, ensuring seamless market entry and long-term growth through expert QP support

Pros and Cons of Working with a CRO

July 31, 2025

Pros and Cons of Working with a CRO

Explore the pros and cons of working with a Contract Research Organization (CRO) and how ProPharma sets a new standard in clinical development success.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Simplifying Global MLR Review: Local Expertise at a Global Scale

August 4, 2025

Simplifying Global MLR Review: Local Expertise at a Global Scale

Struggling to streamline MLR review across international markets? Discover how our team helped a leading pharmaceutical company reduce review timelines, ensure regulatory compliance, and eliminate...

Case Study Successfully Executing a Tech Transfer in a Week - ProPharma

July 29, 2025

Successfully Executing a Tech Transfer in a Week

Discover how ProPharma supported a $3B pharmaceutical tech transfer that was executed in just 3 days, relocating five complex product lines. The plan included FDA alignment, pre-approved protocols,...

Case Study Obesity – Accelerated Timelines - ProPharma

July 29, 2025

Obesity – Accelerated Timelines

A mid-size biotech needed fast U.S. market entry for an obesity trial. ProPharma activated 20 sites in 30 days and enrolled 300+ patients—meeting goals despite an increased sample size. Strategic...

Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

July 22, 2025

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...

MAH Essentials: Ensuring Compliance for European Market Entry

July 10, 2025

MAH Essentials: Ensuring Compliance for European Market Entry

This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and...

News & Insights

Orchestrating Excellence: How ProPharma Bridges Vendors to Deliver Unified, High-Quality Outcomes

August 7, 2025

Orchestrating Excellence: How ProPharma Bridges Vendors to Deliver Unified, High...

Discover how ProPharma enhances collaboration and quality in drug development by expertly coordinating and communicating with multiple vendors for unified, high-quality outcomes.

European Marketing Authorization Success: The Critical Role of Quality and Compliance

August 4, 2025

European Marketing Authorization Success: The Critical Role of Quality and Compl...

Achieve European market success with robust quality and compliance solutions, ensuring seamless market entry and long-term growth through expert QP support

Pros and Cons of Working with a CRO

July 31, 2025

Pros and Cons of Working with a CRO

Explore the pros and cons of working with a Contract Research Organization (CRO) and how ProPharma sets a new standard in clinical development success.

Previous Post Arrow Next Post Arrow
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Simplifying Global MLR Review: Local Expertise at a Global Scale

August 4, 2025

Simplifying Global MLR Review: Local Expertise at a Global Scale

Struggling to streamline MLR review across international markets? Discover how our team helped a leading pharmaceutical company reduce review timelines, ensure regulatory compliance, and eliminate...

Case Study Successfully Executing a Tech Transfer in a Week - ProPharma

July 29, 2025

Successfully Executing a Tech Transfer in a Week

Discover how ProPharma supported a $3B pharmaceutical tech transfer that was executed in just 3 days, relocating five complex product lines. The plan included FDA alignment, pre-approved protocols,...

Case Study Obesity – Accelerated Timelines - ProPharma

July 29, 2025

Obesity – Accelerated Timelines

A mid-size biotech needed fast U.S. market entry for an obesity trial. ProPharma activated 20 sites in 30 days and enrolled 300+ patients—meeting goals despite an increased sample size. Strategic...

Previous Resource Arrow Next Resource Arrow
Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

July 22, 2025

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...

MAH Essentials: Ensuring Compliance for European Market Entry

July 10, 2025

MAH Essentials: Ensuring Compliance for European Market Entry

This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and...

Previous Webinar Arrow Next Webinar Arrow